| Literature DB >> 33975983 |
Sang Pil Kim1, Juhyun Lee2, Sung Kwang Lee2, Do Hyung Kim3.
Abstract
BACKGROUND: Tracheoesophageal fistula (TEFs) is a rare condition that requires complex surgical treatment. We analyzed the surgical outcomes of TEF reported in the literature and at Pusan National University Yangsan Hospital using standardized techniques.Entities:
Keywords: Esophagus; Trachea; Tracheal resection; Tracheoesophageal fistula
Year: 2021 PMID: 33975983 PMCID: PMC8181696 DOI: 10.5090/jcs.21.012
Source DB: PubMed Journal: J Chest Surg ISSN: 2765-1606
Fig. 1Schematic diagram of tracheal resection and end-to-end anastomosis. (A) The trachea is resected below and above the site of the fistula. The fistulous site in the esophagus is exposed between the proximal trachea and distal trachea. (B) The edges of the esophageal defect are debrided and a double-layer closure is made. (C) Because the repair site of the esophageal defect and the anastomosis site of trachea reconstruction are located at different levels, an additional muscle flap interposition is not performed.
Fig. 2Schematic diagram of fistula division and direct closure of the tracheal and esophageal defect. (A) The fistulous tract is divided and the fistula between the esophagus and trachea is exposed. (B) The membranous tracheal defect is closed directly with interrupted sutures. The esophageal defect is closed by a double layer. (C) To avoid close contact with both repair sites, a flap of strap muscle is interposed between the esophagus and trachea. (D) In 1 case, division of the fistula was performed using a stapler due to a large fistula (>5 cm). We decided that the fistula would be divided by a stapler as a modification of primary repair. Tracheal resection was impossible because the fistula size was >5 cm; hence, division using a stapler was performed.
Perioperative characteristics of patients (n=8)
| Characteristic | Value |
|---|---|
| Age (yr) | 58.5 (38.3–77.5) |
| Sex | |
| Male | 3 (37.5) |
| Female | 5 (62.5) |
| Body mass index (kg/m2) | 22.2 (20.0–28.4) |
| Cause | |
| Post-intubation or tracheostomy TEF | 7 (87.5) |
| Post-esophageal surgery, conduit necrosis | 1 (12.5) |
| Preoperative intubation state | |
| Tracheostomy | 6 (75.0) |
| Intubation | 0 |
| None | 2 (25.0) |
| Preoperative mechanical ventilation | 2 (25.0) |
| Comorbidity | |
| Cerebrovascular | 4 (50.0) |
| Cardiovascular | 0 |
| Respiratory disease | 1 (12.5) |
| Others | 4 (50.0) |
| Other preoperative treatment for TEF | 0 |
| Time from diagnosis to surgery (day) | 5 (1.3–19.3) |
Values are presented as median (range) or number (%).
TEF, tracheoesophageal fistula.
Postoperative results
| Variable | Value |
|---|---|
| Approach | |
| Cervical | 7 (87.5) |
| Thoracotomy | 1 (12.5) |
| Trachea management | |
| Tracheal resection and end-to-end anastomosis | 5 (65.5) |
| Primary repair | 2 (25.0) |
| Division with stapler | 1 (12.5) |
| Resection length (cm) | 2.5 (1.3–3.4) |
| Esophageal treatment | |
| Primary repair | 6 (75.0) |
| Stapling | 1 (12.5) |
| Diversion | 1 (12.5) |
| Other concomitant operation | 2 (25.0) |
| Muscle flap interposition | 2 (25.0) |
| Operation time (min) | 177.5 (108.8–335.0) |
| Estimated blood loss (mL) | 100.0 (50.0–237.5) |
| Postoperative bleeding (mL for 24 hours) | 50.0 (5.0–81.3) |
| Mechanical ventilation (day) | 1.5 (0.3–2.8) |
| Intensive care unit stay (day) | 6.0 (2.3–23.8) |
| Hospital stay (day) | 33.5 (18.5–173.5) |
| 30-Day mortality | 0 |
| Morbidity | 4 (50.0) |
| Complications | |
| Tracheoesophageal fistula recurrence | 1 (12.5) |
| Stenosis | 1 (12.5) |
| Dehiscence or granulation | 2 (25.0) |
| Vocal cord palsy | 0 |
| Pneumonia or respiratory failure | 1 (12.5) |
| Long-duration tracheostomy or T-tube | 2 (25.0) |
Values are presented as number (%) or median (range).
Surgical procedures in various studies on the treatment of tracheoesophageal fistula
| Reference | Total | Trachea | Esophagus | Muscle interposition | ||||
|---|---|---|---|---|---|---|---|---|
| Repair | TREE | Other technique | Repair | Other technique | ||||
| Mathisen et al. [ | 38 | 9 (23.7) | 29 (76.3) | 5 (13.2): end to end esophageal anastomosis | 34 (89.5) | |||
| Baisi et al. [ | 29 | 26 (89.7) | 1 (3.4) | 2 (6.9): conservative treatment | 7 (24.1) | 2 (6.9): one stage reconstruction (stomach,2) | 27 (93.1) | |
| Macchiarini et al. [ | 32 | 12 (37.5) | 14 (43.8) | 6 (18.8): indirect closure with muscle flap | 3 (9.4) | 3 (9.4): esophageal diversion with second reconstruction | ||
| Fiala et al. [ | 5 | 0 | 5 (100.0) | 5 (100.0) | 5 (100.0) | |||
| Camargo et al. [ | 14 | 0 | 14 (100.0) | 0 | 0 | |||
| Shen et al. [ | 35 | 28 (80.0) | 3 (8.6) | 4 (11.4): indirect closure with muscle flap (2); indirect closure with esophagus (2) | 18 (51.4) | 17 (48.6): esophageal diversion without reconstruction (4); esophageal diversion with second reconstruction (9); one-stage reconstruction (4) | 28 (80.0) | |
| Muniappan et al. [ | 36 | 14 (38.9) | 22 (61.1) | 20 (55.6) | 3: esophageal diversion without reconstruction (1); end-to-end esophageal anastomosis (1); skin graft (1) | 36 (100.0) | ||
| Marulli et al. [ | 25 | 15 (60.0) | 8 (35.0) | 2 (8.0): indirect closure with muscle flap; in direct closure with bio-absorbable patch | 24 (96.0) | 1 (4.0): end-to-end esophageal anastomosis | 18 (72.0) | |
| Foroulis et al. [ | 13 | 13 (100.0) | 0 | 13 (100.0) | 13 (100.0) | |||
| Bibas et al. [ | 20 | 11 (55.0) | 9 (45.0) | 19 (95.0) | 1 (5.0): esophageal diversion with second reconstruction (1) | 20 (100.0) | ||
| Yang et al. [ | 22 | 0 | 0 | 22 (100.0): double patch | 22 (100.0): one-stage reconstruction with stomach | 0 | ||
| Bolca et al. [ | 11 | 0 | 9 (81.8) | 2: indirect closure with esophagus (1); patch repair with bovine pericardium (1) | 9 (81.8) | 1 (9.1): one-stage reconstruction (1); patch repair with bovine pericardium (1) | 10 (90.9) | |
| Liu et al. [ | 5 | 0 | 5 (100.0) | 5 (100.0) | 0 | |||
| Puma et al. [ | 10 | 0 | 7 (70.0) | 3 (30.0): trachea resection of other site trachea stenosis and primary repair fistula | 10 (100.0) | 10 (100.0) | ||
| Present (2020) | 8 | 2 (25.0) | 5 (62.5) | 1 (12.5): division with stapler | 6 (75.0) | 2 (25.0): esophageal diversion with second reconstruction (1); division of large fistula with endo- stapler | 2 (25.0) | |
Values are presented as number (%). Inclusion criteria: studies from 1991 to 2020 of ≥5 patients undergoing surgical treatment for acquired benign tracheoesophageal fistula that reported outcomes with surgery-specific data. TREE, tracheal resection and end-to-end anastomosis.
Postoperative results of various studies on the treatment of tracheoesophageal fistula
| Reference | TEF surgery per year (cases/year) | No. (%) | ||||||
|---|---|---|---|---|---|---|---|---|
| Morbidity | Mortality | TEF recurrence | Stenosis | Other trachea problem | Pneumonia, respiratory failure, or sepsis | T-tube or tracheostomy | ||
| Mathisen et al. [ | 2.4 (38/12) | 10 (26.3) | 4 (10.5) | 2 (5.3) | 1 (2.6) | 2 (5.3) | 3 (7.9) | 2 (5.3) |
| Baisi et al. [ | 1.6 (29/18) | 7 (24.1) | 1 (3.4) | 2 (6.9) | 1 (3.4) | 0 | 0 | 4 (13.8) |
| Macchiarini et al. [ | 1.6 (32/20) | 7 (21.9) | 1 (3.1) | 1 (3.1) | 2 (6.3) | 2 (6.3) | 10 (31.3) | 2 (6.3) |
| Fiala et al. [ | 0.2 (5/27) | 0 | 0 | 0 | 0 | 0 | 0 | |
| Camargo et al. [ | 0.9 (14/15) | 4 (28.6) | 0 | 0 | 0 | 2 (14.3) | 1 (7.1) | 5 (35.7) |
| Shen et al. [ | 1.2 (35/30) | 19 (54.3) | 2 (5.7) | 3 (8.6) | 2 (5.7) | 2 (5.7) | 12 (34.3) | 2 (5.7) |
| Muniappan et al. [ | 1.9 (36/19) | 20 (55.6) | 1 (2.8) | 4 (11.1) | 1 (2.8) | 2 (5.6) | 4 (11.1) | 10 (27.8) |
| Marulli et al. [ | 2.5 (25/10) | 8 (35.0) | 0 | 0 | 1 (4.0) | 2 (8.0) | 3 (12.0) | 2 (8.0) |
| Foroulis et al. [ | 1.9 (13/7) | 4 (30.8) | 3 (23.1) | 1 (7.7) | 0 | 0 | 3 (23.1) | 1 (7.7) |
| Bidas et al. [ | 1.3 (20/15) | 11 (55.0) | 1 (5.0) | 1 (5.0) | 3 (15.0) | 1 (5.0) | 4 (20.0) | 2 (10.0) |
| Yang et al. [ | 2.2 (22/10) | 4 (18.2) | 0 | 0 | 0 | 1 (4.5) | 1 (4.5) | |
| Bolca et al. [ | 1.1 (11/10) | 2 (18.2) | 2 (18.2) | 0 | 0 | 0 | 0 | 2 (18.2) |
| Liu et al. [ | 1.0 (5/5) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Puma et al. [ | 0.7 (10/15) | 5 (50.0) | 1 (10.0) | 1 (10.0) | 0 | 0 | 0 | 4 (40.0) |
| Present (2020) | 0.9 (8/9) | 4 (50.0) | 0 | 1 (12.5) | 1 (12.5) | 2 (25.0) | 1 (12.5) | 2 (25.0) |
Inclusion criteria: studies from 1991 to 2020 of ≥5 patients undergoing surgical treatment for acquired benign tracheoesophageal fistula that reported outcomes with surgery-specific data.